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ANTIMITOTIC, ANTIGENIC, AND STRUCTURAL RELATIONSHIPS OF NITROGEN , 
MUSTARD AND ITS HOMOLOGUES · 
E. J. VAN SCOTI, M.D., AND R. .J. YU. Pn.D. 
ABSTRACT 
Of the three degradation products of nitrogen mustard (mechlorethamine. H:-./2) only 
N-methyl-2-chloroethyl-2·hydroxyethylamine was antimitotically active and cross-reactive 
to HN2 in tests for delayed hypersensitivity. The other two degradation products, 
N, N'-dimethyl-N. :-.l'bis(2-chloroethyl) piperazinium and ~-methyldiethanolamine, were 
neither antimitotlcally active nor antigenically cross-reactive to HN:l. Thirteen of 17 HN2 
homologues tested were found to be antimitotically active, but only 5 of them were 
cross-reactive to HN2 in regard to delayed hypersensith ity. From structure function 
analysis it is concluded that with open-chain de rival ives cross-reactivity to H'\12 requires 
only a 2-chloroethylamino group as one determinant unit; a substituent with 2 carbon atoms 
such as ethyl, ethanol, and ethoxy at the nitrogen atom determim•d a specificity tor 
cross-reactivity to HN2. With cyclic derivatives. however. the ring size determines 
specificity: 6- and 7- but not 5-membered ring compounds were cross-reactive to Hl\:2. These 
results are potentially applicable to the therapy of cutaneous disease. 
... 
Recent reexplorations of therapeutic effective 
ness of topically applied mechlorethamine (H~2) 
in the management of mycosis fungo ides [1. 2] and 
psoriasis [3-5) have focused attention on two 
properties of the drug which may augment or 
complicate its pharmacologic activity, namely its 
antimitotic and antigenic properties. Therapeutic 
effectiveness of topically applied HN2 in mycosis 
fungoides has been generally thought to be due to 
its antimitotic (cytotoxic) action on the intracuta-
neous neoplastic cells of this lymphoma, although 
how this action might be mediated needs clarifica-
tion [2). Apart from the therapeutic effects that 
seem to be due to direct cytotoxicity are distinct 
beneficial responses of the disease that follow 
delayed hypersensitivity reactions to the drug [l ). 
The latter phenomenon raises the question of 
whether the drug's antigenic properties in some 
way are responsible for the therapeutic effective-
ness in mycosis fungoides, even though allergic 
reactions may not always be overtly expressed 
clinically. 
In contrast, the therapeutic responsiveness of 
psoriasis treated with topical HN2 more clearly 
seems associated with the drug's antimitotic prop-
erties and decidedly not to antigenic properties, 
since delayed hypersensitivity reactions to the 
drug provoke only adverse effects, including 
marked exacerbations of the disease. 
Thus, in connection with the treatment of myco-
sis fungoides the property of antigenicity of HN2 
can be a desirable accompaniment to its antimi· 
totic property. In connection with the treatment of 
psoriasis the reverse prevails. Determining the 
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presence or absence of these properties in homo- • 
logues of H~2 is desirable for (1) under~tanding 
the mechanism of therapeutic action of this rate-"" 
gory ot drugs on mycosi~ fungoides. and (2) iden-
tifying a "safe" homologue for use in psoriasis. i.e .. ., 
one thai is antirnitotically acti\'e but lacking in , 
antigenicity. A first step in this direction has been 
made in the study reportl'd here, in which degrada- " 
tion products of HN2 and HN2 homologues have 
been evaluated for antimitotic properties. and for '-
antigenic cross-reactivity to H~2 itself as mea-
sured hy whether they provoke delayed hypersensi-
tivity reactions when topically applied to patients 
with known hypersensitivity to HN2. ,. 
MATERIALS Al\0 METHODS 
Nitrogen mustard (mechlorethamine hydro(hlorideJ 
and it~ homologue~. except otherwise indicated, were ... 
purchased from Aldrich Chemtcal Company, Inc., :\1il· 
waukee, Wi~consin, and Pfaltz and Bauer, Inc .. Flushing. -
:0.:. Y. The degradation of H~2 wa~ carried out with minor 
modification accord in!( to a method nf Golumbic et al [6, • 
ij. 
Virginal female ICR mice, .') to i weeks old. were u~ed " 
to test for direct antimitolir activity on vaginal epithe· 
lium (8). Ten mice were used for each te~t compound " 
which was prepared in water or ethanol: water. 1: :l. 
Podophyllin for intraperitoneal (ipl injection was pre-
pared in ethanol: propylene glycol I: 4. 
In n routine 8·hr test. compound;; were instilled • 
intraval(inally (IVagl at time lero in a volume ofO 05 ml. 
This dose wa" repeated 2 hr later at which lime 2 mg oft. 
podophyllin were injected intraperitoneatty !ipl in a 
volume of 0.1 mi. All mice were killed hy cervical., 
dil>location 6 hr later, i.e. , 8 hr after initial instillation of 
te~t drug. In 24- and 48-hr screening tests, the same .; 
procedure was used eJtcept that one additional identical 
dose was instilled 1\'ag 16 hr earlier in the former and :~ 
additional doses were administered IVag at 16, 2·1, and 40 
hr earlier in the latter. The vagma was removed en bloc • 
and fixed in 10% buffered formalin . Tram.verse sections 
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f.- wert' cut at 6 p nod stained Y.ith hematoxylin and eosin. 
The numher ol mitotic cell!; per l~nph of mucosa as 
1' measured alon~ the bru.al layer ol the muco,a wa~ 
determined hit.tologicall~ bv mean' r•f l'n ol'ular micrnm-
... eter and t>XPr£'"'ed as miloses/cm . 
Th(• tP''" for cross-reacttvtty w HX~ 111 delayed 
h~·pel"!--eU..IltVIl) were perlormed on lht• untnvnlved ~kin 
• of patients havin~t psoriasi5 or myrnRtK lungotdf'» who 
. were knu11 n 111 have cutaneous aller~n tc fresh solutions of 
H:\2 duL• tu pnur tnpicaltherapeuttr exposure The ,kin 
of I hef.e patient,; elicited delayed hvpe,.en!\itl\'tty reac-
tion,, ronsi,.ting nt intense erythema anrl vbiculation. 
\\ ithin 2-1 IH hr tollowing nonocclu~ive application of 
fresh ~H2 ~>olution, I pg tn 0.05 mi. applied to :J x 5 em 
site' nl nurmnl-appeanng "km Test t•ompounds in vari· 
ous ct>ntt'ntr~tliont< up to 500 111U'O.O.i ml v•erl' stmtla:rly 
te,ted for cro~s ·reucttvll) of delayed hypersensitivity in 
patient~ allergic to Hl'<2 and for l"inHlr\ irritancy m 
patwnh 111 whom Ht\~ wa:. m u.~e thernpeuttcally and 
who were knnwn not to be aller~:ic to H'\'2. 
TABLE I 
., 
MitotJr count.~ m e~troel'nlc t·agir,al Ppllhl'lium of min• after /\'a11 m.•tillation of test compound~ and IP 
admini~tration of podoph\'1/in 
----
='umh~r Conn•n· .\ltt•""'- 'cm '\umber Conn·n !\'lnc"e'/cm 
Tt'lll rompuunrl uf trutwn 
on1mnl~ 
"' 
ll:onl(t' 
--
Xnne tcnntreoll 23 u - 67 1:16 
H~2 9 O.lll 21- 93 
i ().07 2-:lO 
.:-.'-methyldt"l hanolamine 10 (() G2-;).'i2 
i w• Ill ·3:18 
. ~ '-dtmethyl-.'<. t\'-bis Ill n.n:, :!i- :!:32 
t2·chloruel hyll pipers- 8 n.r. .'i!\ · :ul5 
ll!rnium' 
,. j I ~·methyl-2-chloroethyl- H1 n.n1 6 ·22:1 
2 hvdn•:net h\ !amine« 10 0 .113 I ~ - 126 10 I (l,ll,) 66b 
oor·H~2 II IJ.f, I :11 Ill 
.'i I 9 · :161 
8 2 0 5·1 
Benzyl nur-HN:.!• 9 ll. l 19 :!f;R 
9 ru·, 6 -8:1 
Chlorurnbucil 8 I 7-~29 
6 o.;,• I 1 -:~11 
.j I" I I :1:3 
Cyclophm.phamide 8 I 1:! 171 
111 I" H :no 
• 
8 I ' ·l!l 172 
9 ·I 21- :l-10 
Awidine 9 I 2-279 
!; I . 5- ltl2 
• 2-c hloruethy In mine R I ~-67-t 
~ 8 r,• :t!-375 
i Ill 102- 726 
-
•• 4 Pc•clnphyllin J.P .. :1 mg 
• Ttost run fnr 24 hr 
'Cnntanunated with !'<-methyldiethannlnmine 
:'11~ 
dum 
1---
237 
~~ I 
111 
16.J 
185 
150 
s-; 
~I I 
li> I 
il 
22 
9 
14F 
-12 
187 
-1.) 
11 
108 
12:1 
p-_, 
216 
71 
21 
:!3:J 
273 i 
2'16 
N,:"\ 
e h 
dimethyi-2-C'hJoro-
~·lumirw 
Chlor 
'\i,"' 
lith 
diechyl2-chloro-
vlamine 
N 12· <'hlornct hvl l · PY rroli-
" 
din 
~·1'1· rhluro~t·thyll·ptperi·l 
din l' 
'\ t:! 
phc 
l·hlnmcthvll-mnr· I 
>line 
N t2 
me 
C"hlornt'lhyl) hexa-
th~·l"nt'tmine 
' 'I 
chi 
dii!l(lpropyl-2-
nmethylamine 
'\ t:! 
hi: 
mcthuxyethyll-'\ 
nzyl-:!-rhlon~ethyl 
in£• am 
"l 'N-dthen7yl·· :!·chloro-
ylamme eth 
7-12·< 
ph_ 
hloruethyll·theo-
vllinL· 
"' 
trat um 
anamols <; H.ange 
9 10 I 291 
; 2" .t -3.'19 
8 ;; l:l-110 
li !;• 7 216 
A O..'i 11- Jilii 
i 110 561 
8 2 :l9 198 
7 .. f) 20· -119 
fi :! ltl-107 
6 U-277 
li 2 2- tO 
6 111 -219 
i ti.L 6- lfiO 
6 0.5 0-72 
5 2 10- -11 
8 2 56 :135 
5 :! 96 -162 
8 ;, i 4-:J94 
8 .. , 11 -336 
- •contaminated with :'\-methvlda"thannlamin~· ond \,\ Dmtethvl-X.N'·bi.'lt2·chloroethyl)ptperalintum 
• Synthe~ized in our Laboratory of Medtctnal Chemistry 
~ ' Tt.'5t run fc1r -41\ hr 
1\te-
ian 
44 
12 
11-t 
6B 
29 
248 
112 
122 
28 
83 
20 
31 
136 
·l 
23 
82 
149 
230 
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TABLE II 
Structur~·actiuity r~lationship of HN2 and its dl'~radatU>n product& 
- -----
C<>mpuund 
H:\2 
N ·met hyl-2-chloroet hyl -2-hydroxyet hylamine 
N. N '-dimethyl-N. :'ll'-bis(2-chloroethyl)piperazinium 
N-methyldil'thanolamine 
Strut cure Anttmitotic effects 
-----------
+ 
CH, 
I (i)N-CH,CH,CI 
c0cH, 
J~Ju, 
E9!'1-CH,CH,CI 
I 
CH, 
CH,CH,OH 
I 
CH,:\ 
\ 
CH,CH,OH 
__ l -~ 
Cro65·re&~· 
ti\•it\ With ... 
H~2deht)ttd 
hyperscn· 
Mitlvitv• 
.. 
... 
.. 
-----.. 
• Eliciting delayed hypen;ensiti\'ity in patients allergic to HN2 
RESULTS A:'\0 l!'liTERJ>JU:TATIOS 
Antimitotic Action 
Mouse vaginal specimens were classified as 
being in either the estrogenic or progestational 
phase of the estrus cycle on the ba.o;is of histologic 
characteristics. Only those data from animals with 
estrogenic vaginal epithelia were taken for compar-
ison. The results are shown in Table l. 
Our experience to date using the mouse vaginal 
system to identify drugs with primary antimitotic 
properties have indicat<>d that a test drug is 
substantiallv antimitotic when the median mitotic 
count is low.er than 100/cm. Of the three degrada-
tion products of HN2. only N-methyl-2-chloroeth-
vl-2-hvdroxvethvlamine i~ antimitol icallv acti\'e. 
Two o"t her prod~cts, rliethanolamin11 and piperazi-
nium derivatives. were inactive although the latter 
moll'cule contains two chloroethylamino func-
tional groups. 
Of the four full-homologlws of H~2. nor-H:\'2, 
benzyl nor-HN2, and chlorambucil were an-
timitotically activP. in the IVag te~t. Cyclophus-
phamtde was mactive in o-, .2·1·, and 48-hr te:.ts . ._ 
Ten of I:l hemi-homulogue., of HN2 testl'd were 
ant imitotically active. On the basis of weight-
concentration ~, N ·d iisopropyl -2-chloroet hyla· 
mine nppeared to be the most potent antimitotic"' 
compound in this srries. 
.. 
lJelayed Hypersensitivity Cross-Reaction with HN~ 
A total of 7 patients ha\'ing psoriasis or mycosis 
fungoidcs who were exquisitely allergic to HN~ 
were selected for the studic~ of cross-reactivity tn 
11:"112. Of the three degradation product!:\ of HNzl 
only !\-methyl-2-chloroethyl-2-hydroxyethylamine, 
elicited delayed hypersensitivity in patient:- aller-
gically reartivr to freshly prepared HN2 solution 
(Table Ill Since this molet·ule has only one 2-
chlornethylamino group, I he result~ apparent I )I 
indicate that the his(2-chloroethyl)amino struc-
ture is not required for cross-reactivity to HN2t 
The other two degradation products, piperazinium 
and clicthanolamine derivatives. were neither nn "' 
timitnt ically active nor cross-reactive allergically 
to their parent compound HN2. Since the piperazi-
.,. 
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TARLE Ill 
Structurl!-oiCIIIlty rPiatinn.~hlp of HS2 and lt., homolopue' 
--~-·T---
t"nmpnund Strurtur!' ,\ntlm ltn11C' t•lft····~ 
:381 
Crn~ ... ·rtac· 
(1\'it\' \\lth 
II :\2 rl~lav('d 
h,. ,,.....,.eit· 
~iuvity• 
--- ---- +~----
.> nor -Hl\:2 
...,. Brnzyl nnr-H:S:! 
'"~'Chlorambucil 
~ Cyclophosphamide 
·~ Aziridme 
... 
Chlnmet hvlamtnl' 
Oimrl h\' J. chluroct h~·laminr 
Chlorochnhnl' 
_Dil'th\ l-chlorol'thv lamine 
Chlnroet hvl pyrrolid ine 
Chloroethvl piperidine-
ChlorO<·thvl morphulinr 
... 
Chloroothyl hl'xamrthyleneimine 
., 
.. 
Dii.,opropvl chloruethylamine 
... 
HOOCtC H,l,C,H,:-.::tCH,CH ,Cll, 
0 -~\II <_,P-~<CII,CH,CI <, 
+ 
ICH,),l':CH,CH,Cl 
CH,CH, 
I 
CH,CH, 
.\CH,C H,CI 
C H,CH, 
/ \ 
CH, :'\CH,CH,Cl 
/ 
CH,CH, 
CH CH I , . 
0 '\CH,CH,Cl 
I 
CH,CH, 
C H,CH, 
c:. \ I :'\CH,CH,Cl 
c'\ / 
CH,C ll , 
+ 
tC H,J,CH 
I 
:\l'H 1GH,Cl 
tCH,J,CH 
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TABI.I•: Ill-Continued 
T J . 
T 
Clll!i:S-reJtt 
(1\'ll)' .. i th 
Cmnpound Struclltre I Antlmttolic Hl'2 <lrlft•<>d efft.-rts hypcn;en Slll\' 11\ .. 
:\1t>l hnxyet hyl benlylchluroel hylomint• 
Oihenzyl-chloroethylamtne jG,H,CH,),NCII,CH,CI 
Chloroethyl theophyllme 
1 
• Eliciting delayed hypen;ensttinty to patients allergic to H~:l 
nium compound, which po:;sesse~ two N-mcth· 
yi -N. Cl-chloroethyl lnrnmu ~roups, was not ('f!lss· 
n•nrt i\'e, it i~ evident t hnt this functional group 
docs not con,titutc the !'ullicicnt structural unit 
n•quircd for the property •)I ao -rent•th·ity. 
=-:ont· of the four lull-homologue' of H~2 elicited 
delayer! hypen;ensitivit~ to HN2 .tlthough the~e 
muh•t•ules contain the his(~·t·hlornet hvllamino 
~roup (Table III). · 
In the hemi-homologU(' :;erics the two ~impJe,_t 
"tructures are chloroethvlaminr nnd its cvcliu·d 
form, aziridine. The form.cr wns neither anti"mitot j. 
t'ltlly net i\'e nor cross-react iH• with HN2 t1'ahle 
II II . Aziridine was nnt imitot it· but not cross-rent·· 
ti\e nller~ically. Jt appcn"' then that in addition to 
one 2-rhloroethylamino group a~ n prerequired 
determinant unit fur cro;;,...rcortivity to H;;-:2, a 
,..erond substituent is TI.'<JUired . In the serie~ of 
o1wn-rhain derivative:;, dirnethvl, trimethyl. dii,.,o · 
propyl. and dibenzyl derivnt iVl'l' were all an 
timitotil'ally active hut not cross·rl'ncti\'e to HN:! 
On the other hand, dil'thvl and methoxvethvl 
durivat i\'C~ were hot h nnt i1;1itnt it·allv activ-e ami 
ulso cross-reactive to H~~. It -,.eem" thtll 
ethyl!CH,CH,J. ethanol anrl ethoxyi(-OCii, 
CH,-1 but not a second chloroethyl tClCH,CH 1) 
grnup attached to the nitrogen atom determines 
the specificity for t'ros,.·react i'·lty tn H:-:2. 
When the nitrogen atom is n part of a ring 
system. the molet·ule with a ;; membered ring 
appt•nrs to be not cross-react ivl' to HI\~. lor 
exumple pyrrolidine and thcuphylline derivat 1\'Cs 
('l'a h\(• III). They were, h<>WC\'er. noss-reart ive 
when the rtn~ size increased to G or 7 atom~ . It j,.. 
not known at present whethc>r conlormation ol the 
ring plays any role in the sperificity of cro$S·tCill'· 
tivity to H~2. 
msn ssro:-; 
The re~ult.; ot thi:- studv l£•nd themsdves to 
immediall• applicability to human di,.ea,..e in some 
circumstanres. to potential opplicnbility in other 
circumstonccs, and to uncertain applicability in • 
'till others. ,\, an exumplt• of immediate applica· 
.. hility, we have lound the property of topknl 
nntimiwtit· activit\' fiiUJH.l for nor-H:-.:2 in the 
nHHisl' \"ngina tc>:l . tn correlntt• with therapeutic 
effl•t:tivene:;s u~uin:'l cutuneous lesion:; of mycoSL'> , 
fungoirlt·;; lnpicolly treated with !<olution~ of thi,.; 
l'CIITIJIOUnd lunpuhlishccll 
From thc"c dinicnl trials in mycosis fungoide" it 
mny be anticipated that nor·H~2 would he tht>ra- f 
pcuticnlly etTecti\'e ns n topical agent on le:-ions of 
psorins1s-an example of potential applicability. • 
Our finding in the pre$cnt 1\tudy that nor-H:-\2 
does not cros:;-reat•t to H:-o::? ns an antigen f()r .. 
dclnyt>d hypersensit ivit~· cunnot he construed . ., 
however. ns predicting l hut nllr-HN~ is not primar-
ily IIlli igenic itself. for mdl't'd Wl' have observed one ~ 
pntil'nt with mycllsi.,.. fungnidi!S, treated only tnpi-
cnlh· with 5<1lution,. of nnr-11:-\2, who de\'eloped " 
delayed hyper.;ensiti\'ity to nor-H::\2. Interest· 
ing\y, Cfrn'!'·reactivity to HN2 did not exist in this " 
patient. 
An area of uncertain npplicahility is in connct·· 
tion with development of better understandin~ of 6 
the met• han i~ms uf induct ion ut delayed hypersrn-
!lith•ity. The fact thnt IJN:l, and probably a num- ot 
ht-r of itli nnalogues nnd humologues. are among the 
mu~t putf'nt antigenil' uh tunce.~ for indut·ing t 
delayed hyperscnsiti\'ity in man needs to be un-
derscored. It ,.eem:- rea onablc that thi." family nf ' 
compounds is exploitable for further studil'S of 
determinants of antigeni<'uy. 
1 
" 
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~ Viewing HN2 and/or its de!{Tadatinn products as 
represen tative of this family of compounds. one is 
~1mpre~sed by the multiplicity of properties or 
attributes possessed by the nitrogen mustards. 
~hese compounds are carcinogenic as well as 
carcinostatic. immunosuppressive as well as anti-
• genic. and cytotoxic as well as cvtotrophic: an 
~example of the latter i!l their stimulation of mela-
nogenesis 19]. The ethylene amine moiety 
·• r-CH2CH 2N-I of their structure is common to a 
number of normal biochemical compounds, e.g., 
·•catecholamines. histamine, choline. The wide 
range of relationships found in the structural and 
) functional properties of the nitrogen mustards still 
make them very interesting agents for study, even 
~ though their prototype, mechlorethamine, was in -
-troduced into medicine more than 30 years ago 
(10]. 
The authors acknowledge the technical excellence of 
~Mr. Bernol Leitch who did the mitotic counting in this 
study. 
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